Table 1.
Triplet non-invasive monitoring by middle cerebral artery peak systolic velocity (MCA PSV) for foetal anaemia throughout pregnancy
| 23+6 weeks | 24+4 weeks | 25+4 weeks | 26+3 weeks | 27+3 weeks | 28+3 weeks | 28+6 weeks | 30+5 weeks | 31+6 weeks | 32+6 weeks | 33+2 weeks | ||
| Triplet 1 | MCA PSV | 37 | 37 | 38 | 42 | 44 | 56 | 50 | 38 | 43 | 48 | 50 |
| MOM | 1.2 | 1.1 | 1.1 | 1.2 | 1.2 | 1.5 | 1.3 | <1 | <1 | 1.0 | 1.1 | |
| Triplet 2 | MCA PSV | 37 | 37 | 37 | 41 | 46 | 56 | 45 | 32 | 45 | 52 | 54 |
| MOM | 1.2 | 1.1 | 1.1 | 1.1 | 1.2 | 1.5 | 1.1 | <1 | 1.0 | 1.1 | 1.2 | |
| Triplet 3 | MCA PSV | 29 | 37 | 32 | 40 | 38 | 53 | 48 | 29 | 54 | 55 | 56 |
| MOM | <1 | 1.1 | <1 | 1.1 | 1 | 1.4 | 1.2 | <1 | 1.2 | 1.1 | 1.5 |
MCA PSV, middle cerebral artery peak systolic velocity; MOM, multiples of the median.